Comparison of effects of thiazolidinediones on cardiovascular risk factors: observations from a clinical practice.
about
Identification of a novel mitochondrial protein ("mitoNEET") cross-linked specifically by a thiazolidinedione photoprobeCurrent therapeutic options in type 2 diabetes mellitus: a practical approachType 2 diabetes therapy. A pathophysiologically based approach.The effects of oral anti-hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes.Long-term glycaemic control with pioglitazone in patients with type 2 diabetes.Peroxisome proliferator-activated receptor ligands in atherosclerosis.Potential adjunctive therapies in adolescents with type 1 diabetes mellitus.The role of thiazolidinediones in the treatment of patients with type 2 diabetes mellitus.Pioglitazone: an antidiabetic drug with the potency to reduce cardiovascular mortality.Pioglitazone: an antidiabetic drug with cardiovascular therapeutic effects.Pioglitazone plus glimepiride: a promising alternative in metabolic control.An observational study of the effect of two thiazolidinediones on blood lipid levels: Rosiglitazone and pioglitazone in routine clinical practiceEfficacy and tolerability of pioglitazone in patients with type 2 diabetes mellitus: comparison with other oral antihyperglycaemic agents.Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes.Discontinued drugs in 2006: renal, endocrine and metabolic drugs.Chemoprevention of lung carcinogenesis by the combination of aerosolized budesonide and oral pioglitazone in A/J mice.Ligand and coactivator identity determines the requirement of the charge clamp for coactivation of the peroxisome proliferator-activated receptor gamma.Pioglitazone increases apolipoprotein A-I production by directly enhancing PPRE-dependent transcription in HepG2 cells.Pioglitazone in a subgroup of patients with type 2 diabetes meeting the criteria for metabolic syndrome.67 th annual meeting of the American Diabetes Association.Paradoxical HDL-C reduction during rosiglitazone and fibrate treatment.Effects of pioglitazone on lipid and lipoprotein profiles in patients with type 2 diabetes and dyslipidaemia after treatment conversion from rosiglitazone while continuing stable statin therapy.
P2860
Q28211498-2AB58550-586A-47E2-B0FA-77C1FCCB8842Q33723387-1BAD7316-0ED1-4B6B-94F3-BCE5A286C02CQ34576374-DC0416CC-9EF9-40FC-A57E-873F08CBE414Q35640348-DEE16EEE-8C77-44AB-8AFD-3A8E4D62D804Q35728336-8E4A8FEC-79DA-4FA1-A095-4A67D17F3566Q35925566-283A4962-7B06-4294-8944-4295A034CC44Q35931204-DF1A10FF-93A7-4033-A06B-DF49944F0C6DQ36070247-528CA608-9A89-4950-8155-94DCE942D5E0Q36407383-BEEB3805-1D05-4A71-9F2E-9623DD004DB8Q36569766-3F254C6E-7AA6-4A07-9EA4-8239336DC735Q36861895-2B4068A0-5C8B-47F9-A500-C7741BB56C79Q37719114-FCF6A07C-CBFB-429F-B313-0D4F5EBA5ADDQ37794960-A82A92FC-C575-4317-9D13-5D37DEA15AEFQ38349512-F209913A-1FE4-408D-B30C-6C55D1313CC8Q38460231-0796ABDE-605D-472E-BBD7-81016FE414F3Q39581456-4E402E16-2663-41CB-8CF3-98A721F1A4A6Q40681053-C3E9EAA6-12EE-4C6B-8673-E457BB630F76Q41831875-DDF1210C-56D2-4337-BEAC-A5A30C103D24Q46457607-39BC3DA9-8CAA-4CCA-B69F-FB7B2D64C228Q46961262-5002C1AB-4868-41E3-8D18-6D06A146247FQ47582945-20CF5005-7816-47B8-B570-1BBDB7E44212Q51496275-8D4FCBE0-B63D-4BF3-8F81-110009605A16
P2860
Comparison of effects of thiazolidinediones on cardiovascular risk factors: observations from a clinical practice.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Comparison of effects of thiaz ...... ions from a clinical practice.
@en
Comparison of effects of thiaz ...... ions from a clinical practice.
@nl
type
label
Comparison of effects of thiaz ...... ions from a clinical practice.
@en
Comparison of effects of thiaz ...... ions from a clinical practice.
@nl
prefLabel
Comparison of effects of thiaz ...... ions from a clinical practice.
@en
Comparison of effects of thiaz ...... ions from a clinical practice.
@nl
P356
P1433
P1476
Comparison of effects of thiaz ...... ions from a clinical practice.
@en
P2093
Altheimer MD
P304
P356
10.4158/EP.7.3.162
P577
2001-05-01T00:00:00Z